Close
May 17, 2024 10:36AM
May 17, 2024 08:02AM
May 17, 2024 08:00AM
May 17, 2024 07:00AM
May 16, 2024 07:09PM
May 16, 2024 06:54PM
May 16, 2024 04:01PM Nuvalent Inc (NUVL) Receives U.S. FDA Breakthrough Therapy Designation for NVL-655
May 16, 2024 07:35AM
May 16, 2024 07:31AM
May 16, 2024 07:31AM
May 16, 2024 07:03AM
May 16, 2024 07:02AM
May 16, 2024 07:01AM
May 16, 2024 06:14AM AstraZeneca (AZN) reports Phase III trial of sipavibart long-acting antibody met primary endpoints
May 16, 2024 06:01AM
May 16, 2024 05:22AM
May 15, 2024 04:02PM
May 15, 2024 09:29AM
May 15, 2024 09:01AM
May 15, 2024 08:45AM
May 15, 2024 08:00AM CASI Pharma (CASI) Receives FDA Clearance On The iNDA For CID-103
May 15, 2024 07:49AM
May 15, 2024 07:30AM
May 15, 2024 07:03AM
May 15, 2024 06:31AM
May 14, 2024 04:15PM
May 14, 2024 04:08PM
May 14, 2024 04:00PM Curis (CRIS) Announces Additional Data from TakeAim Leukemia Study
May 14, 2024 02:32PM
May 14, 2024 08:45AM
May 14, 2024 08:39AM
May 14, 2024 08:34AM
May 14, 2024 08:33AM
May 14, 2024 08:02AM
May 14, 2024 07:36AM Calliditas Therapeutics' (CALT) Partner Everest Medicines Starts Commercial Launch of Nefecon in China
May 14, 2024 07:31AM
May 14, 2024 07:30AM
May 14, 2024 07:30AM
May 14, 2024 06:01AM
May 13, 2024 08:31PM
May 13, 2024 09:36AM
May 13, 2024 08:50AM Outlook Therapeutics (OTLK) Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5010 as a Treatment for Wet AMD
May 13, 2024 08:33AM
May 13, 2024 08:03AM
May 13, 2024 08:01AM
May 13, 2024 07:30AM
May 13, 2024 07:04AM
May 13, 2024 07:04AM
May 13, 2024 06:47AM Merck (MRK) Provides Update on Phase 3 KeyVibe-010 Trial Evaluating an Investigational Coformulation of Vibostolimab and Pembrolizumab
May 13, 2024 06:01AM

67,084 total articles have been posted to this category.

Sign-up to StreetInsider.com Premium to see all today's market moving FDA reports.